Genus Plc remains under-appreciated despite a 70% return and recent FDA approval for its gene-editing platform. Learn why Greenwood Investors remains bullish.

Genus' estimated fair value is UK£31.90 based on 2 Stage Free Cash Flow to Equity. With UK£29.70 share price, Genus appears to be trading close to its estimated fa ...

Genus stock opened at GBX 2,005 ($26.60) on Wednesday. Genus has a 12 month low of GBX 1,424 ($18.89) and a 12 month high of GBX 2,155 ($28.59). The stock has a fifty day simple moving average of GBX ...

Genus is a rare global leader from the UK, responsible for 15% of pigs and 9% of cattle bred globally. Its expanding royalty model, growing capacity, and scientific focus are positives. Many headwinds ...

Investing.com -- Genus PLC (LSE:GNS), a global animal genetics company, on Friday announced Friday that it performed strongly in the first half of fiscal year 2026, with results exceeding management ...